ConductScience.org, home

Paper35106968

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis.

Grayson PC and 11 others. Arthritis Rheumatol, 2022. Cited by 163 papers, by iCite.

Cite this record

ConductScience Library. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis. Papers, record 35106968. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35106968

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis.
PubMed
Journal
Arthritis Rheumatol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Practice Guideline, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
163
iCite
Relative citation ratio, by iCite
17.5
iCite
Revised in PubMed
2026-05-18
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Grayson PCPeter Chttps://orcid.org/0000-0002-8269-9438
2Ponte CCristina
3Suppiah RRavi
4Robson JCJoanna Chttps://orcid.org/0000-0002-7939-5978
5Craven AAnthea
6Judge AAndrew
7Khalid SSara
8Hutchings AAndrew
9Luqmani RARaashid A
10Watts RARichard Ahttps://orcid.org/0000-0002-2846-4769
11Merkel PAPeter Ahttps://orcid.org/0000-0001-9284-7345
12DCVAS Study GroupGroup

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Churg-Strauss SyndromeMajor topic
Adult
Aged
Female
Humans
Male
Middle Aged
Sensitivity and Specificity

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
MR/N011775/1Medical Research CouncilUnited KingdomPubMedPubMed
ZIAAR041204NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT07591753Long-Term Safety and Effectiveness of Mepolizumab 300 mg in Europe (Mepo LTF Study)Results

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in35106953New Classification Criteria for Small-Vessel Vasculitis: Is Antineutrophil Cytoplasmic Antibody Inclusion Their Major Advance?https://conductscience.org/library/papers/35106953PubMed
Comment in35714043
A methodologic problem and a conceptual issue related to the new 2022 antineutrophil cytoplasmic antibody-related vasculitis criteria sets: comment on criteria sets approved by the American College of Rheumatology Board of Directors and the European Alliance of Associations for Rheumatology Executive Committee.
https://conductscience.org/library/papers/35714043PubMed

Download CSV of comments and corrections

Cited by86

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 163 citations.

PMIDTitleJournalYearIn PapersSource
42893335Beyond Pneumonia: A Case of Steroid-Responsive Pulmonary Eosinophilia With Atypical p-ANCA Positivity.Cureus2026https://conductscience.org/library/papers/42893335PubMed
42871696When Eosinophilic Granulomatosis With Polyangiitis (EGPA) Looks Like Granulomatosis With Polyangiitis (GPA): Navigating a Complex Case of Anti-neutrophil Cytoplasmic Antibodies (ANCA) Vasculitis.Cureus2026https://conductscience.org/library/papers/42871696PubMed
42827517Bronchiectasis as the Sentinel Manifestation of ANCA-Associated Vasculitis: A Case Report and Literature Review.Respirol Case Rep2026https://conductscience.org/library/papers/42827517PubMed
42824523Life-Threatening Eosinophilic Granulomatosis With Polyangiitis During Omalizumab Therapy for Chronic Urticaria: Missed Diagnosis, Induction, or Unmasking?Cureus2026https://conductscience.org/library/papers/42824523PubMed
42806340Identification of clinical-biological endophenotypes in patients with eosinophilic granulomatosis with polyangiitis using unsupervised machine learning: a real-world study.Respir Res2026https://conductscience.org/library/papers/42806340PubMed
42666554New perspectives in the treatment of chronic eosinophilic pneumonia in the era of targeted therapies.Front Immunol2026https://conductscience.org/library/papers/42666554PubMed
42653119EGPA at Diagnosis: A Comprehensive Single-Center Profile of Laboratory Findings and Clinical Evidence.Int J Mol Sci2026https://conductscience.org/library/papers/42653119PubMed
42568486Eosinophilic granulomatosis with polyangiitis complicated by pulmonary aspergillosis and misdiagnosed as allergic bronchopulmonary aspergillosis: a case report.Front Med (Lausanne)2026https://conductscience.org/library/papers/42568486PubMed
42558283Mortality risk stratification in antineutrophil cytoplasmic antibody-associated vasculitis: baseline severity, accumulated damage burden and cardio-renal vulnerability in a Chinese two-center cohort.Front Med (Lausanne)2026https://conductscience.org/library/papers/42558283PubMed
42487962Case Report: From misdiagnosis to successful treatment using mepolizumab in ANCA-negative severe EGPA-clinical lessons in eosinophil-targeted therapy.Front Med (Lausanne)2026https://conductscience.org/library/papers/42487962PubMed
42417783Factors Associated With the High Prevalence of Metabolic Syndrome in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.Arq Bras Cardiol2026https://conductscience.org/library/papers/42417783PubMed
42396140Beyond clinical criteria: emerging biomarkers and advanced imaging in the diagnosis, monitoring and treatment of vasculitides.Front Med (Lausanne)2026https://conductscience.org/library/papers/42396140PubMed
42367766Biological functions and clinical efficacy of IL-5/IL-5Rα-targeted therapies across eosinophilia-associated diseases.Front Immunol2026https://conductscience.org/library/papers/42367766PubMed
42346872Renal Involvement in Pediatric Small-Vessel Vasculitis: A Comprehensive Review of Clinical Impact, Diagnosis, and Management.Med Sci (Basel)2026https://conductscience.org/library/papers/42346872PubMed
42190692The SHIPE Index: A Tertile-Based Approach to Predict End-Stage Kidney Disease in ANCA-Associated Vasculitis.J Korean Med Sci2026https://conductscience.org/library/papers/42190692PubMed
42137655Eosinophilic Granulomatosis With Polyangiitis (EGPA) Manifesting as Giant Cell Arteritis After Initiating Treatment With Dupilumab: An Unusual Clinical Presentation.Cureus2026https://conductscience.org/library/papers/42137655PubMed
42051495Expert review and recommendations on the diagnosis and therapeutic management of eosinophilic granulomatosis with polyangiitis.Front Immunol2026https://conductscience.org/library/papers/42051495PubMed
42011880Monoclonal antibodies targeting IL-5/5R or IL-4/13 pathways in eosinophilic myocarditis: a single-centre experience and systematic literature review.Eur Heart J Cardiovasc Pharmacother2026https://conductscience.org/library/papers/42011880PubMed
42004946Long-term outcomes remain unchanged despite reduced glucocorticoid exposure in ANCA-associated vasculitis: the multicentre REVEAL cohort study.Front Immunol2026https://conductscience.org/library/papers/42004946PubMed
41947311Cochlear Implantation in Autoimmune Inner-Ear Disease: Outcome and Patient-Reported Benefit.Laryngoscope2026https://conductscience.org/library/papers/41947311PubMed

See all 86 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PRTN35657PubTator's text mininghttps://conductscience.org/library/genes/5657

Source NCBI Gene

Download CSV of genes

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
MEPOLIZUMABCHEMBL2108429Results1https://conductscience.org/library/drugs/CHEMBL2108429

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • References
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35106968

GET https://conductscience.org/api/papers/v1/35106968/cited_by?page=2